Tirzepatide, a recently approved medication, is generating significant interest in the healthcare community as a possible treatment for both managing blood sugar and weight loss . This groundbreaking drug works by targeting two separate receptors, GLP-1 and GIP, leading to better glucose control and substantial slimming in testing. While preliminar